Skip to content
Screener

Twist Bioscience Corporation TWST Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$6.12B+43.2%
Danaher logo
DanaherDHR
$6.52B+15.8%
Azenta logo
AzentaAZTA
$10.73M
Agilent Technologies logo
Agilent TechnologiesA
$496M-7.3%
Illumina logo
IlluminaILMN
$289M-17.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$9.71M+523%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$7.25B+335%
Enterprise value$7.24B+365%
P/S17.7×+13.1×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)March 31,2026September 30,2025
Total current liabilities$119,976$91,406
Operating lease liability, net of current portion85,39861,750
Liability related to the sale of future revenue15,00015,000
Other non-current liabilities[1]746747
Total liabilities$221,120$168,903
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.00001 par value —200,000 and 200,000 shares authorized at March 31, 2026 and September 30, 2025, respectively; 62,154 and 60,632 shares issued and outstanding at March 31, 2026 and September 30, 2025, respectively$1

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's other non-current liabilities?
Twist Bioscience Corporation (TWST) reported other non-current liabilities of $746K in Q1 2026.
How has Twist Bioscience Corporation's other non-current liabilities changed year-over-year?
Twist Bioscience Corporation's other non-current liabilities increased by 65.4% year-over-year, from $451K to $746K.
What is the long-term trend for Twist Bioscience Corporation's other non-current liabilities?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's other non-current liabilities has grown at a -38.0% compound annual growth rate (CAGR), from $5.07M to $747K.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Twist Bioscience Corporation's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude